QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

CTMX

QT40CytomX Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
2.95
-0.01-0.34%
OverviewShort InterestFilings
CTMXQT40CytomX Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
2.95-0.34%

Latest SEC Filings

Form category
Filing Date ▾Report DateFormDescriptionFilingDocument
Jun 17, 2026Jun 17, 20264Statement of changes in beneficial ownership
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 15, 2026May 15, 2026SC 13G/ASC 13G/A
May 07, 2026May 07, 20268-KCurrent report
May 07, 2026May 07, 202610-QQuarterly report
Apr 30, 2026Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 20, 2026Apr 20, 2026PRE 14APRE 14A
Apr 16, 2026Apr 16, 2026SC 13GBeneficial ownership statement (passive)
Mar 26, 2026Mar 26, 2026SC 13G/ASC 13G/A
Mar 19, 2026Mar 19, 20268-KCurrent report
Mar 19, 2026Mar 19, 20264Statement of changes in beneficial ownership
Mar 19, 2026Mar 19, 20264Statement of changes in beneficial ownership
Mar 19, 2026Mar 19, 20264Statement of changes in beneficial ownership
Mar 19, 2026Mar 19, 20264Statement of changes in beneficial ownership
Mar 18, 2026Mar 18, 2026424B5424B5
Mar 16, 2026Mar 16, 20268-KCurrent report
Mar 16, 2026Mar 16, 202610-KAnnual report
Mar 16, 2026Mar 16, 2026424B5424B5
Mar 16, 2026Mar 16, 2026S-3ASRS-3ASR
Mar 04, 2026Mar 04, 2026SC 13GBeneficial ownership statement (passive)
Feb 17, 2026Feb 17, 2026SC 13G/ASC 13G/A
#1 / 25 of 296
Page
▼
/ 12